Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

NCT01684787 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Peginterferon alfa-2a + ribavirin in normal ALT
DRUG: Peginterferon alfa-2a + ribavirin in elevated ALT

Sponsor

Miguel Santin